| |
PROLOGUE
International Experience With Prescription Drug Policy
| The first 100 words of the full text of this article appear below. |
PROLOGUE: The good news for U.S. policymakers who seek to learn from other countries how to design a Medicare drug benefit is that the international community has a wealth of experience in handling pharmaceutical benefit policy for a wide variety of public and private programs. The bad news is that no single approach has been unambiguously validated by all of this experience.
In a study of reference pricing (RP) systems in several countries, for example, Panos Kanavos and Uwe Reinhardt find evidence of troubling theoretical contradictions. One of the arguments against RP systems that include on-patent products grouped in therapeutic . . . [Full Text of this Article]

What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. G. Neilson
Baumol's Curse on Medicine
J. Am. Soc. Nephrol.,
June 1, 2008;
19(6):
1049 - 1053.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Hollenbeck, R. L. Dunn, D. C. Miller, S. Daignault, D. A. Taub, and J. T. Wei
Volume-Based Referral for Cancer Surgery: Informing the Debate
J. Clin. Oncol.,
January 1, 2007;
25(1):
91 - 96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Blumenthal
New Steam from an Old Cauldron -- The Physician-Supply Debate
N. Engl. J. Med.,
April 22, 2004;
350(17):
1780 - 1787.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Watanabe, R. W. Dollens, W. N. Malatestinic, and R. A. Browne
Is a Paradigm Shift in US Healthcare Reimbursement Inevitable?
Circulation,
March 30, 2004;
109(12):
1456 - 1459.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Future of Family Medicine Project Leadership Commi
The Future of Family Medicine: A Collaborative Project of the Family Medicine Community
Ann. Fam. Med,
March 1, 2004;
2(suppl_1):
S3 - S32.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|